Taurine

The reviewed hip-fracture trial reported no mortality improvement during the first postoperative year despite changes in oxidative-stress markers.

A change in a laboratory marker, a test score and everyday function are different outcomes. A statistically detectable result does not by itself tell us whether someone would notice a worthwhile difference.

Check the measured endpoint, comparison and study population. The full profile preserves effect estimates and the source's clinical-significance assessment, including when that assessment is not supplied.

The claim to test: Improved oxidative-stress markers establish a human lifespan benefit.

What the reviewed records say:

The gap: This short perioperative regimen differs from long-term supplementation. Detailed adverse-event review and other human studies remain pending.

Durability, effects in other populations and healthy-lifespan outcomes need their own evidence.

Independent replication, meaningful human outcomes, longer follow-up and better safety reporting would make these results easier to interpret.

This short perioperative regimen differs from long-term supplementation. Detailed adverse-event review and other human studies remain pending.